Under a microscope, chlamydia doesn’t look like a typical bacterium. It’s extremely small, lives inside human cells, and changes shape depending on its life stage. What you actually see depends on the type of microscope and staining technique used, but the hallmark finding is a dark cluster of tiny particles packed inside a host cell, often pushing the cell’s nucleus to one side.
Two Forms, Two Shapes
Chlamydia trachomatis exists in two distinct forms throughout its life cycle, and each looks different under magnification. The first is the elementary body, which is the infectious particle that spreads between cells. Elementary bodies are roughly spherical and remarkably tiny, about 0.3 micrometers in diameter. For perspective, that’s roughly 100 times smaller than a typical human cell. These particles are dense and compact, with a rigid outer membrane that helps them survive outside a host cell.
Once an elementary body enters a human cell, it transforms into the second form: the reticulate body. This is the metabolically active version that divides and multiplies. Reticulate bodies are larger, averaging about 0.5 micrometers in diameter, and appear rounder and less dense. They lack a traditional cell wall, which makes them fragile outside their host cell but allows them to grow and divide freely within it. After multiplying (roughly every 2 to 3 hours), reticulate bodies convert back into elementary bodies and burst out of the cell to infect new ones.
What Inclusions Look Like
The most recognizable feature of a chlamydia infection under a light microscope is the inclusion body. This is a membrane-bound pocket inside an infected cell, packed with chlamydial organisms at various stages of development. Under staining, these inclusions appear as a distinct mass sitting in the cell’s cytoplasm, often capping or pressing against the nucleus. A visible gap typically separates the inclusion from the nuclear material, which helps trained microscopists identify it.
As the infection progresses over its 7 to 21 day incubation period, inclusions grow larger and can occupy a significant portion of the host cell. In advanced infections, a single inclusion may contain hundreds of elementary and reticulate bodies crowded together.
How Staining Changes the View
Chlamydia is too small and too faint to see clearly without staining. The method used determines the color and clarity of what appears on the slide.
With Giemsa staining, one of the oldest and most straightforward techniques, chlamydial inclusions appear pinkish-blue against the surrounding cell material. This method works particularly well on conjunctival scrapings from the eye, where it has historically been used to diagnose trachoma. The blue-tinged cluster of organisms stands out against the lighter cytoplasm of the epithelial cell.
Iodine staining takes a different approach. Because chlamydia produces glycogen inside its inclusions, iodine reacts with that glycogen and turns the inclusion a dark brown color. This is actually unique to C. trachomatis among chlamydial species, making it a useful identifying feature. However, iodine staining provides less structural detail than other methods.
Direct fluorescent antibody (DFA) testing uses antibodies tagged with a fluorescent marker that bind specifically to proteins on the surface of elementary bodies. Under a fluorescence microscope, the chlamydial particles glow bright apple-green against a dark background. The best fluorescence comes from antibodies that target a protein called MOMP, which is evenly distributed across the bacterial surface and produces a clean, uniform glow. DFA testing has about 75% to 85% sensitivity compared with culture methods.
What Electron Microscopy Reveals
Standard light microscopes can show inclusions and stained elementary bodies, but the fine structural details of chlamydia only become visible under electron microscopy. At this level of magnification, the difference between elementary bodies and reticulate bodies becomes strikingly clear. Elementary bodies appear as electron-dense (dark) spheres with a tightly condensed core, while reticulate bodies look lighter and more diffuse, with their genetic material spread loosely throughout.
Electron microscopy has also revealed tiny rod-like projections covering the surface of chlamydial cells. These rods are about 6 to 8 nanometers wide and 50 nanometers long, anchored through the outer membrane by a ring-shaped structure. They’re made of helically arranged protein subunits and appear at every stage of the life cycle, even on the smallest elementary bodies. Researchers believe these surface projections play a role in either infectivity or bacterial replication, though their exact function isn’t fully settled.
Transmission electron micrographs of a fully developed inclusion body show a striking image: a large, membrane-bound vacuole filled with a mix of dark, compact elementary bodies and lighter, larger reticulate bodies, all nestled within the cytoplasm of an otherwise normal-looking human cell. The host cell’s nucleus and mitochondria remain visible nearby, giving a sense of just how much cellular real estate the infection commandeers.
Why Microscopy Is No Longer the Standard Test
Despite the detailed images microscopy can produce, it’s no longer the primary way chlamydia is diagnosed. Nucleic acid amplification tests (NAATs), which detect chlamydial DNA, have largely replaced microscopic methods in clinical practice. NAATs detect 20% to 50% more infections than culture or older lab tests, with sensitivity typically above 90% and specificity at 99% or higher.
The gap is especially dramatic at certain body sites. For rectal chlamydia infections, culture catches only about 27% of cases, while the most sensitive molecular test catches 93%. Microscopy-based methods like DFA sit somewhere in between but still fall well short of molecular testing. The practical result is that most people diagnosed with chlamydia today never have their infection visualized under a microscope at all. The technique remains valuable in research settings and in regions where molecular testing isn’t available, but for routine diagnosis, it has been superseded by faster, more accurate technology.